1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3 Executive Summary
4. Market insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases
4.2.2. Development of CLIA-Waived Molecular POC Tests
4.2.3. Venture Capital Funding for Development of POC Molecular Diagnostics Products
4.2.4. Lack of Skilled Professionals and Need for POC Molecular Diagnostics Testing in Low Resource Setting
4.2.5. Rapid Decision Making in Emergency Care
4.3. Restraints
4.3.1. Tedious Regulatory Approval Process
4.3.2. Pricing Pressures Owing to Reimbursement Cuts
4.4. Opportunity
4.4.1. Growing Opportunities from Emerging Countries
5. POC Molecular Diagnostics Market, by Product
5.1. Introduction
5.2. Kits & Assays
5.3. Analyzers/Instruments
5.4. Software and Services
6. POC Molecular Diagnostics Market, by Technology
6.1. Introduction
6.2. Real-Time Quantitative Polymerase Chain Reaction (Rt-QPCR)
6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4. Other Technologies
7. POC Molecular Diagnostics Market, by Application
7.1. Introduction
7.2. Respiratory Diseases
7.3. Sexually Transmitted Diseases (STDs)
7.4. Hospital Acquired infections (HAIs)
7.5. Cancer/Oncology
7.6. Prenatal/Neonatal Testing
7.7. Other Applications
8. POC Molecular Diagnostics Market, by End User
8.1. Introduction
8.2. Clinics and Diagnostics Laboratories
8.3. Hospital Outpatient Departments & ICUs
8.4. Research and Academic institute
9. POC Molecular Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis
11. Company Profiles
11.1. Abbott Laboratories (Including Alere)
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Quidel Corporation
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. F. Hoffmann-La Roche Ltd
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Danaher Corporation
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.6. Biomérieux SA
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. Meridian Bioscience Inc.
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. Mesa Biotech Inc.
11.8.1. Business Overview
11.8.2. Product Portfolio
11.8.3. Strategic Developments
11.9. DxNa, LLC.
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Biocartis Group NV
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global POC Molecular Diagnostics Market: Impact Analysis of Market Drivers (2019–2027)
Table 2 Global Number of New Cancer Cases Among 65 Years and Older (In Millions)
Table 3 Who Prevalence of Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis, by Region (In %)
Table 4 Some POC Molecular Diagnostic Products with CLIA Waiver
Table 5 Global POC Molecular Diagnostics Market: Impact Analysis of Market Restraints (2019–2027)
Table 6 Global POC Molecular Diagnostics Market Size, by Product, 2017-2027 ($Million)
Table 7 POC Molecular Diagnostic Kits & Assays Prices
Table 8 Commercialized POC Molecular Diagnostic Kits & Assays
Table 9 POC Molecular Diagnostic Kits & Assays Under Development
Table 10 Recent Strategic Developments for Kits & Assays
Table 11 Global POC Molecular Diagnostic Kits & Assays Market Size, by Country/Region, 2017-2027 ($Million)
Table 12 Key Companies offering POC Molecular Diagnostic Analyzers/Instruments
Table 13 Cost of POC Molecular Diagnostic Analyzers/Instruments
Table 14 Global POC Molecular Diagnostics Analyzers/Instruments Market Size, by Country/Region, 2017-2027 ($Million)
Table 15 Key Companies Providing POC Molecular Diagnostic Software/Services
Table 16 Global POC Molecular Diagnostics Software and Services Market Size, by Country/Region, 2017-2027 ($Million)
Table 17 Global POC Molecular Diagnostics Market Size, by Technology, 2017-2027 ($Million)
Table 18 Key Companies offering RT-qPCR Based POC Molecular Diagnostic Products
Table 19 Comparison of RT-qPCR and Isothermal Technology
Table 20 Global RT-qPCR Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 21 Key Companies offering INAAT Based POC Mdx Products
Table 22 Global INAAT Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 23 Global Other Technologies Based POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 24 Global POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 25 Commercialized POC Molecular Diagnostic Products for Respiratory Diseases
Table 26 Recent Strategic Developments for Respiratory Disease Diagnosis
Table 27 Global POC Molecular Diagnostic Market Size for Respiratory Diseases, by Country/Region, 2017-2027 ($Million)
Table 28 Commercialized POC Molecular Diagnostic Products for Sexually Transmitted Diseases (STDs)
Table 29 POC Molecular Diagnostic Products for Sexually Transmitted Diseases (STDs) Under Development
Table 30 Global POC Molecular Diagnostics Market Size for Sexually Transmitted Diseases (STDs), by Country/Region, 2017-2027 ($Million)
Table 31 Commercialized POC Molecular Diagnostic Products for Healthcare-Associated Infections (HAIs)
Table 32 Global POC Molecular Diagnostics Market Size for Healthcare-Associated Infections (HAIs), by Country/Region, 2017-2027 ($Million)
Table 33 Commercialized POC Molecular Diagnostic Products for Cancer/Oncology
Table 34 Global POC Molecular Diagnostics Market Size for Cancer/Oncology, by Country/Region, 2017-2027 ($Million)
Table 35 Commercialized POC Molecular Diagnostic Products for Neonatal/Prenatal Testing
Table 36 Global POC Molecular Diagnostics Market Size for Prenatal/Neonatal Testing, by Country/Region, 2017-2027 ($Million)
Table 37 Commercialized POC Molecular Diagnostic Products for Other Applications
Table 38 Global POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 39 Global POC Molecular Diagnostics Market Size for Clinics and Diagnostic Laboratories, by Country/Region, 2017-2027 ($Million)
Table 40 Key Companies offering POC Molecular Diagnostic Products for Hospital Acquired infections
Table 41 Global POC Molecular Diagnostics Market Size for Hospital Outpatient Departments & ICU, by Country/Region, 2017-2027 ($Million)
Table 42 Global POC Molecular Diagnostics Market Size for Research & Academics institutes, by Country/Region, 2017-2027 ($Million)
Table 43 Global POC Molecular Diagnostics Market Size, by Country/Region, 2017-2027 ($Million)
Table 44 North America: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 45 North America: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 46 North America: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 47 North America: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 48 North America: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 49 U.S.: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 50 U.S.: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 51 U.S.: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 52 U.S.: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 53 Canada: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 54 Canada: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 55 Canada: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 56 Canada: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 57 Europe: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 58 Europe: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 59 Europe: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 60 Europe: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 61 Europe: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 62 Germany: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 63 Germany: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 64 Germany: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 65 Germany: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 66 France: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 67 France: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 68 France: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 69 France: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 70 U.K.: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 71 U.K.: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 72 U.K.: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 73 U.K.: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 74 Italy: Cancer Prevalence Cases, 2010 and 2020
Table 75 Italy: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 76 Italy: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 77 Italy: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 78 Italy: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 79 Spain: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 80 Spain: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 81 Spain: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 82 Spain: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 83 RoE: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 84 RoE: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 85 RoE: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 86 RoE: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 87 Asia Pacific: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Table 88 Asia Pacific: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 89 Asia Pacific: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 90 Asia Pacific: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 91 Asia Pacific: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 92 Japan: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 93 Japan: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 94 Japan: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 95 Japan: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 96 China: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 97 China: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 98 China: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 99 China: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 100 India: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 101 India: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 102 India: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 103 India: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 104 RoAPAC: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 105 RoAPAC: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 106 RoAPAC: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 107 RoAPAC: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 108 Latin America: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 109 Latin America: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 110 Latin America: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 111 Latin America: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 112 Middle East & Africa: POC Molecular Diagnostics Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 113 Middle East & Africa: POC Molecular Diagnostics Systems Market Size, by Technology, 2017-2027 ($Million)
Table 114 Middle East & Africa: POC Molecular Diagnostics Market Size, by Application, 2017-2027 ($Million)
Table 115 Middle East & Africa: POC Molecular Diagnostics Market Size, by End User, 2017-2027 ($Million)
Table 116 Number of Developments by the Major Players During 2016-2020
Table of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 The Kits and Assays Segment Dominates the Global POC Molecular Diagnostics Market
Figure 8 Global POC Molecular Diagnostics Market Size, by Technology, 2019-2027 ($Million)
Figure 9 Global POC Molecular Diagnostics Market Size, by Application, 2019-2027 ($Million)
Figure 10 The Clinics & Diagnostic Laboratories Segment Will Dominate the Global POC Molecular Diagnostics Market during the forecast Period by 2025
Figure 11 Point of Care Molecular Diagnostics Market, by Region ($Million)
Figure 12 Market Dynamics
Figure 13 Global Geriatric Population, 1950-2020 (In Thousand)
Figure 14 Disposable Personal Income in China (In $)
Figure 15 Percent of Major Disease Groups to Total Disability-Adjusted Life Years (DALYs) in India, 1990 and 2016
Figure 16 Global POC Molecular Diagnostics Market Size, by Product, 2019-2027 ($Million)
Figure 17 Global POC Molecular Diagnostics Market Size, by Technology, 2019-2027 ($Million)
Figure 18 Global POC Molecular Diagnostics Market Size, by Application, 2019-2027 ($Million)
Figure 19 Global POC Molecular Diagnostics Market Size, by End User, 2019-2027 ($Million)
Figure 20 U.S. Distribution of Outpatient Vs. Inpatient Revenues, 1995 – 2016
Figure 21 Global POC Molecular Diagnostics Market Size, by Region, 2019-2027 ($Million)
Figure 22 North America: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 23 U.S. Influenza Burden (2010-2018)
Figure 24 Canada: Chlamydia and Gonorrhea Infections Cases (2006-2017)
Figure 25 Europe: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 26 Germany: VRE Infection Data for ICUs and Surgical Departments, by Infection Site, 2010-2016 (%)
Figure 27 France: Percentage of Older People (65 Years and Above), 2010-2050
Figure 28 Asia Pacific: POC Molecular Diagnostics Market Size, by Country, 2019-2027 ($Million)
Figure 29 China Population Growth Chart
Figure 30 Key Growth Strategies Adopted by Leading Players -2016-2020
Figure 31 Point of Care Molecular Diagnostics: Competitive Benchmarking
Figure 32 Global Flow Cytometry Market Share, by Key Players, 2018 (%)
Figure 33 Abbott Laboratories: Financial Overview (2017-2018)
Figure 34 Quidel Corporation: Financial Overview (2016-2018)
Figure 35 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
Figure 36 Danaher Corporation: Financial Overview (2016-2018)
Figure 37 Thermo Fisher Scientific Inc..: Financial Overview (2016-2018)
Figure 38 Biomérieux SA: Financial Overview (2016-2018)
Figure 39 Meridian Bioscience Inc.: Financial Overview (2017-2019)
Figure 40 Biocartis Group NV: Financial Overview (2016-2018)